Latest Financials News

Inventis Limited has agreed to sell its Electronic Circuit Designs division for A$2.4 million, while retaining an option to repurchase the business within a year. The move aims to reduce debt and streamline operations ahead of a planned technology-driven growth phase.

Commonwealth Bank of Australia announces a fully franked quarterly dividend of AUD 1.1581 per security on its PERLS XV capital notes, payable in September 2025.

Commonwealth Bank of Australia announces a fully franked quarterly distribution of AUD 1.1405 per security on its PERLS XIV capital note, payable mid-September 2025.

Wiseway Group Limited will seek retrospective shareholder approval for critical related party leases after ASX determines prior approvals were required. The company assures operations remain unaffected as it commissions an independent fairness report.

Commonwealth Bank of Australia announces a fully franked quarterly distribution of AUD 1.1405 per security on its PERLS XIII capital note, payable mid-September 2025.

Commonwealth Bank of Australia announces a fully franked quarterly dividend of AUD 1.1846 per PERLS XII security, payable in September 2025, reflecting steady income for investors.

Bass Oil Limited has raised $925,180 through a non-renounceable rights issue, aiming to complete its Vanessa Acquisition and fuel future growth initiatives.

Simble Solutions Limited has resumed trading on the ASX following the announcement of its capital raise details, ending a recent suspension.

Yowie Group Ltd has formally applied to the Takeovers Panel for a review of its recent decision involving Keybridge Capital Limited, signaling ongoing regulatory scrutiny in this corporate governance matter.

Codeifai Limited has agreed to acquire its main competitor Trust Codes Global Limited, significantly expanding its footprint and product capabilities ahead of the 2027 global shift to 2D barcodes.

S2 Resources Limited launches a discounted Share Purchase Plan allowing eligible shareholders to invest up to $30,000, accompanied by free attaching options exercisable at $0.11. The capital raise supports exploration across key Australian projects.

Opyl Limited’s AI platform TrialKey has partnered with UK insurer Innovatrix to launch a pioneering parametric insurance product that protects biotech firms from the financial risks of clinical trial failures.